Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose naloxone on pain after molar extraction
NCT02976337Phase 2Completed
- Start
- Oct 2017
- Primary completion
- Nov 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of naloxone in Central sensitization (CS), hyperalgesia. Started Oct 2017; status: completed.
02
Drugs
naloxone
03
Conditions
Central sensitization (CS)hyperalgesia
Beyond the preview
Go deeper on NCT02976337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02976337.